James Molloy

Stock Analyst at Alliance Global Partners

(0.36)
# 4,177
Out of 4,960 analysts
33
Total ratings
20.59%
Success rate
-38.23%
Average return

Stocks Rated by James Molloy

Soligenix
Jul 16, 2025
Maintains: Buy
Price Target: $10$6
Current: $3.38
Upside: +77.51%
IGC Pharma
Mar 6, 2025
Reiterates: Buy
Price Target: $3.5
Current: $0.37
Upside: +858.90%
Intensity Therapeutics
Jan 13, 2025
Initiates: Buy
Price Target: $8.5
Current: $0.30
Upside: +2,695.13%
vTv Therapeutics
Dec 9, 2024
Initiates: Buy
Price Target: $35
Current: $16.00
Upside: +118.75%
GeoVax Labs
Nov 11, 2024
Initiates: Buy
Price Target: $15
Current: $0.77
Upside: +1,858.22%
INmune Bio
Oct 21, 2024
Initiates: Buy
Price Target: $20
Current: $2.41
Upside: +729.88%
Scilex Holding Company
Oct 16, 2024
Initiates: Buy
Price Target: $490
Current: $18.87
Upside: +2,496.71%
Tonix Pharmaceuticals Holding
Jul 22, 2024
Maintains: Buy
Price Target: $600$1,100
Current: $37.98
Upside: +2,796.26%
PEDEVCO
Jul 17, 2024
Initiates: Buy
Price Target: $1.75
Current: $0.58
Upside: +201.72%
Pyxis Tankers
Jul 17, 2024
Initiates: Buy
Price Target: $10
Current: $2.70
Upside: +270.36%
Maintains: Buy
Price Target: $9$14
Current: $0.84
Upside: +1,566.67%
Initiates: Buy
Price Target: $30
Current: $1.46
Upside: +1,954.79%
Initiates: Buy
Price Target: $7.5
Current: $1.17
Upside: +539.39%
Reiterates: Buy
Price Target: $20
Current: $7.23
Upside: +176.63%
Maintains: Buy
Price Target: $14$8
Current: $1.91
Upside: +318.85%
Maintains: Buy
Price Target: $10$7
Current: $3.98
Upside: +75.88%
Initiates: Buy
Price Target: $80
Current: $0.93
Upside: +8,531.85%
Initiates: Buy
Price Target: $16
Current: $0.54
Upside: +2,871.22%
Initiates: Buy
Price Target: $280
Current: $4.72
Upside: +5,838.49%
Initiates: Buy
Price Target: $196
Current: $6.50
Upside: +2,910.00%
Initiates: Buy
Price Target: $8,400
Current: $7.20
Upside: +116,543.99%
Initiates: Buy
Price Target: $150
Current: $3.79
Upside: +3,857.78%
Initiates: Buy
Price Target: $938
Current: $1.22
Upside: +76,744.26%
Initiates: Buy
Price Target: $25
Current: $2.92
Upside: +756.16%